These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37554290)

  • 41. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.
    Kolandaivelu K; Swaminathan R; Gibson WJ; Kolachalama VB; Nguyen-Ehrenreich KL; Giddings VL; Coleman L; Wong GK; Edelman ER
    Circulation; 2011 Apr; 123(13):1400-9. PubMed ID: 21422389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influence of biomateriai on focal adhesion kinase of platelet: ex vivo study].
    Wei W; Sun J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):350-2. PubMed ID: 16706364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombus formation at the surface of guide-wire models: effects of heparin-releasing or heparin-exposing surface coatings.
    Aldenhoff YB; Hanssen JH; Knetsch ML; Koole LH
    J Vasc Interv Radiol; 2007 Mar; 18(3):419-25. PubMed ID: 17377189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental evaluation of bleeding complications, thrombogenicity and neointimal characteristics of prosthetic patch materials used for carotid angioplasty.
    Rhee RY; Gloviczki P; Cambria RA; Miller VM
    Cardiovasc Surg; 1996 Dec; 4(6):746-52. PubMed ID: 9013003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Vitro models for thrombogenicity testing of blood-recirculating medical devices.
    Sarode DN; Roy S
    Expert Rev Med Devices; 2019 Jul; 16(7):603-616. PubMed ID: 31154869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Kikuchi S; Tsukahara K; Ichikawa S; Abe T; Minamimoto Y; Kimura Y; Akiyama E; Nakayama N; Okada K; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Circ J; 2020 May; 84(6):975-984. PubMed ID: 32188836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.
    Major TC; Handa H; Annich GM; Bartlett RH
    J Biomater Appl; 2014 Oct; 29(4):479-501. PubMed ID: 24934500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
    Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
    J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The optimal incubation time for in vitro hemocompatibility testing: Assessment using polymer reference materials under pulsatile flow with physiological wall shear stress conditions.
    Blok SLJ; van Oeveren W; Engels GE
    J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2335-2342. PubMed ID: 30697956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinogen binding and platelet retention: relationship with the thrombogenicity of catheters.
    Bailly AL; Laurent A; Lu H; Elalami I; Jacob P; Mundler O; Merland JJ; Lautier A; Soria J; Soria C
    J Biomed Mater Res; 1996 Jan; 30(1):101-8. PubMed ID: 8788111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of biomaterials on endothelial cell thrombogenicity.
    McGuigan AP; Sefton MV
    Biomaterials; 2007 Jun; 28(16):2547-71. PubMed ID: 17316788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
    Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
    Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.
    Badimon JJ; Lettino M; Toschi V; Fuster V; Berrozpe M; Chesebro JH; Badimon L
    Circulation; 1999 Apr; 99(14):1780-7. PubMed ID: 10199872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of comparative thrombogenicity of dog, pig, and human platelets in a hemodialyzer.
    Dewanjee MK; Kapadvanjwala M; Sanchez A; Elson R; Serafini AN; Zilleruelo GE; Sfakianakis GN
    ASAIO J; 1992; 38(2):88-90. PubMed ID: 1421611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immobilisation of a fibrillin-1 fragment enhances the biocompatibility of PTFE.
    Hajian H; Wise SG; Bax DV; Kondyurin A; Waterhouse A; Dunn LL; Kielty CM; Yu Y; Weiss AS; Bilek MM; Bannon PG; Ng MK
    Colloids Surf B Biointerfaces; 2014 Apr; 116():544-52. PubMed ID: 24572497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.
    Yoshizaki T; Tabuchi N; van Oeveren W; Shibamiya A; Koyama T; Sunamori M
    Int J Artif Organs; 2005 Aug; 28(8):834-40. PubMed ID: 16211534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Endothelial Culture Medium Composition on Platelet Responses to Polymeric Biomaterials.
    Lau S; Maier A; Braune S; Gossen M; Lendlein A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radiolabeled platelets.
    Dewanjee MK; Kapadvanjwala M; Cavagnaro CF; Panoutsopoulos GK; Suguihara CY; Elson R; Ezuddin SH; Serafini AN; Zilleruelo GE; Sfakianakis GN
    ASAIO J; 1994; 40(1):49-55. PubMed ID: 8186492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
    Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
    Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.